Cargando…
Potential Drug Candidates to Treat TRPC6 Channel Deficiencies in the Pathophysiology of Alzheimer’s Disease and Brain Ischemia
Alzheimer’s disease and cerebral ischemia are among the many causative neurodegenerative diseases that lead to disabilities in the middle-aged and elderly population. There are no effective disease-preventing therapies for these pathologies. Recent in vitro and in vivo studies have revealed the TRPC...
Autores principales: | Prikhodko, Veronika, Chernyuk, Daria, Sysoev, Yurii, Zernov, Nikita, Okovityi, Sergey, Popugaeva, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692306/ https://www.ncbi.nlm.nih.gov/pubmed/33114455 http://dx.doi.org/10.3390/cells9112351 |
Ejemplares similares
-
Role of Neuronal TRPC6 Channels in Synapse Development, Memory Formation and Animal Behavior
por: Zernov, Nikita, et al.
Publicado: (2023) -
New Positive TRPC6 Modulator Penetrates Blood–Brain Barrier, Eliminates Synaptic Deficiency and Restores Memory Deficit in 5xFAD Mice
por: Zernov, Nikita, et al.
Publicado: (2022) -
Novel Chromone-Containing Allylmorpholines Induce Anxiolytic-like and Sedative Effects in Adult Zebrafish
por: Prikhodko, Veronika A., et al.
Publicado: (2022) -
Pharmacotherapy for Non-Alcoholic Fatty Liver Disease: Emerging Targets and Drug Candidates
por: Prikhodko, Veronika A., et al.
Publicado: (2022) -
Color-Coding Method Reveals Enhancement of Stereotypic Locomotion by Phenazepam in Rat Open Field Test
por: Makarov, Mark, et al.
Publicado: (2023)